UNASSIGNED: To analyse the @entity1 demographics, @entity5 characteristics and follow-up data of @entity1 with recurrence of @entity320 following a negative sentinel lymph node biopsy. A retrospective review of a prospectively maintained @entity320 database was conducted. @entity320 @entity1 who had a negative sentinel lymph node were identified and we performed statistical analysis on their respective demographics, @entity5 histology characteristics and follow-up data. Of 164 @entity1 studied, 40 (24%) had a recurrence of @entity320 at a median of 39.5 months following diagnosis (range 1-92 months). Distant metastases were the most common form of disease recurrence (40% of all recurrences). Increasing @entity5 thickness was an independent predictor of recurrence on multivariate analysis while nodular histology approached significance. Median survival of 6 months was seen following disease recurrence (range 1-126 months). In the setting of a negative sentinel lymph node biopsy, there remains a risk of @entity320 . Distant metastases were the most common form of recurrence. Disease recurrence occurred more frequently in those with thick primary @entity5 . Recurrences occurred at long intervals from diagnosis indicating the need to consider prolonged @entity1 follow-up.

Predictors and patterns of XXXX following a negative sentinel lymph node biopsy.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity320 :: ('MESH:D008545', 'Disease') :: ['melanoma', 'melanoma recurrence', 'Melanoma'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumours', 'tumour']
@entity320 :: (MESH:D008545,Disease) :: ['melanoma recurrence']
